{"name": "Semprus BioSciences",
 "permalink": "semprus-biosciences",
 "crunchbase_url": "http://www.crunchbase.com/company/semprus-biosciences",
 "homepage_url": "http://www.semprusbio.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "SemprusBio",
 "category_code": "biotech",
 "number_of_employees": 27,
 "founded_year": 2006,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@semprusbio.com",
 "phone_number": "617-577-7755",
 "description": "biotech functional medical surfaces",
 "created_at": "Wed Jun 17 04:36:58 UTC 2009",
 "updated_at": "Mon Jun 25 13:55:42 UTC 2012",
 "overview": "\u003Cp\u003ESemprus BioSciences is a venture-backed biomedical company headquartered in Cambridge, Massachusetts. Our innovative, multi-faceted Semprus technology signifies a breakthrough in medical device technology. Our current focus is to develop a vascular access catheter with the first single surface modification that is  designed to simultaneously reduce microbial adherence and thrombus accumulation over the life of the device. In December 2010, the company completed an $18 million Series B financing co-led by SR One, the corporate venture capital arm of GlaxoSmithKline, and Foundation Medical Partners (FMP), a national healthcare venture capital investment firm with a strategic relationship with Cleveland Clinic. Combined with previous financing rounds, Semprus has raised a total of $28.5 million in equity.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       36],
      "assets/images/resized/0004/9007/49007v1-max-150x150.jpg"],
     [[244,
       59],
      "assets/images/resized/0004/9007/49007v1-max-250x250.jpg"],
     [[244,
       59],
      "assets/images/resized/0004/9007/49007v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$27M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://us.ellre.com/a-jjkda2bzTPV",
    "source_description": "Semrus BioSciences Raises $8 Million",
    "raised_amount": 8000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2008,
    "funded_month": 12,
    "funded_day": 14,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "5AM Ventures",
         "permalink": "5am-ventures",
         "image":
          {"available_sizes":
            [[[150,
               104],
              "assets/images/resized/0004/7316/47316v2-max-150x150.jpg"],
             [[250,
               173],
              "assets/images/resized/0004/7316/47316v2-max-250x250.jpg"],
             [[288,
               200],
              "assets/images/resized/0004/7316/47316v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Panagea Ventures",
         "permalink": "panagea-ventures",
         "image":
          {"available_sizes":
            [[[150,
               135],
              "assets/images/resized/0004/9009/49009v1-max-150x150.png"],
             [[210,
               189],
              "assets/images/resized/0004/9009/49009v1-max-250x250.png"],
             [[210,
               189],
              "assets/images/resized/0004/9009/49009v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "b",
    "source_url": "http://www.semprusbio.com/documents/SEMPRUS_BIOSCIENCES_RAISES_ADDITIONAL_18_MILLION.pdf",
    "source_description": "SEMPRUS BIOSCIENCES RAISES ADDITIONAL $18 MILLION",
    "raised_amount": 18000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 12,
    "funded_day": 13,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "SR One",
         "permalink": "sr-one",
         "image":
          {"available_sizes":
            [[[150,
               58],
              "assets/images/resized/0004/8794/48794v2-max-150x150.jpg"],
             [[206,
               81],
              "assets/images/resized/0004/8794/48794v2-max-250x250.jpg"],
             [[206,
               81],
              "assets/images/resized/0004/8794/48794v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company":
        {"name": "GlaxoSmithKline",
         "permalink": "glaxosmithkline",
         "image":
          {"available_sizes":
            [[[150,
               51],
              "assets/images/resized/0005/1020/51020v1-max-150x150.png"],
             [[158,
               54],
              "assets/images/resized/0005/1020/51020v1-max-250x250.png"],
             [[158,
               54],
              "assets/images/resized/0005/1020/51020v1-max-450x450.png"]],
           "attribution": null}},
       "financial_org": null,
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Foundation Medical Partners",
         "permalink": "foundation-medical-partners",
         "image":
          {"available_sizes":
            [[[150,
               42],
              "assets/images/resized/0005/5121/55121v1-max-150x150.png"],
             [[175,
               50],
              "assets/images/resized/0005/5121/55121v1-max-250x250.png"],
             [[175,
               50],
              "assets/images/resized/0005/5121/55121v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "5AM Ventures",
         "permalink": "5am-ventures",
         "image":
          {"available_sizes":
            [[[150,
               104],
              "assets/images/resized/0004/7316/47316v2-max-150x150.jpg"],
             [[250,
               173],
              "assets/images/resized/0004/7316/47316v2-max-250x250.jpg"],
             [[288,
               200],
              "assets/images/resized/0004/7316/47316v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Pangaea Ventures",
         "permalink": "pangaea-ventures",
         "image":
          {"available_sizes":
            [[[150,
               53],
              "assets/images/resized/0010/3069/103069v2-max-150x150.png"],
             [[250,
               89],
              "assets/images/resized/0010/3069/103069v2-max-250x250.png"],
             [[270,
               97],
              "assets/images/resized/0010/3069/103069v2-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "grant",
    "source_url": "http://www.masshightech.com/stories/2011/10/17/daily29-Army-awards-Semprus-BioSciences-1M-to-protect-implants.html",
    "source_description": "Army awards Semprus BioSciences $1M to protect implants",
    "raised_amount": 1000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 10,
    "funded_day": 19,
    "investments":
     []}],
 "investments":
  [],
 "acquisition":
  {"price_amount": 30000000.0,
   "price_currency_code": "USD",
   "term_code": null,
   "source_url": "http://www.masshightech.com/stories/2012/06/25/daily2-Semprus-BioSciences-acquired-by-Teleflex-for-30M.html",
   "source_description": "Semprus BioSciences acquired by Teleflex for $30M",
   "acquired_year": 2012,
   "acquired_month": 6,
   "acquired_day": 25,
   "acquiring_company":
    {"name": "Teleflex",
     "permalink": "teleflex",
     "image":
      {"available_sizes":
        [[[150,
           51],
          "assets/images/resized/0011/6972/116972v1-max-150x150.jpg"],
         [[220,
           75],
          "assets/images/resized/0011/6972/116972v1-max-250x250.jpg"],
         [[220,
           75],
          "assets/images/resized/0011/6972/116972v1-max-450x450.jpg"]],
       "attribution": null}}},
 "acquisitions":
  [],
 "offices":
  [{"description": "HQ",
    "address1": "One Kendall Square",
    "address2": "Building 1400W, 1st Floor",
    "zip_code": "02139",
    "city": "Cambridge",
    "state_code": "MA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [{"description": "Semprus BioSciences has received a $500,000 Phase 2b grant from the National Science Foundation.",
    "stoned_year": 2010,
    "stoned_month": 9,
    "stoned_day": 22,
    "source_url": "http://www.masshightech.com/stories/2010/09/20/daily38-Semprus-BioSciences-scores-500k-NSF-grant.html",
    "source_text": null,
    "source_description": "Mass High Tech",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Semprus BioSciences",
      "permalink": "semprus-biosciences"}},
   {"description": "Gets $500k NSF grant",
    "stoned_year": 2010,
    "stoned_month": 9,
    "stoned_day": 22,
    "source_url": "http://www.masshightech.com/stories/2010/09/20/daily38-Semprus-BioSciences-scores-500k-NSF-grant.html",
    "source_text": null,
    "source_description": "Semprus BioSciences scores $500k NSF grant",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Semprus BioSciences",
      "permalink": "semprus-biosciences"}},
   {"description": "David L. Lucchino, CEO of Cambridge-based Semprus BioSciences, has been elected to the board of directors of the trade association Advanced Medical Technology Association",
    "stoned_year": 2011,
    "stoned_month": 3,
    "stoned_day": 8,
    "source_url": "http://www.masshightech.com/stories/2011/03/07/daily26-Semprus-BioSciences-Lucchino-joins-AdvaMed-board.html",
    "source_text": null,
    "source_description": "Semprus BioSciences' Lucchino joins AdvaMed board",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Semprus BioSciences",
      "permalink": "semprus-biosciences"}}],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        117],
       "assets/images/resized/0004/9008/49008v1-max-150x150.jpg"],
      [[250,
        196],
       "assets/images/resized/0004/9008/49008v1-max-250x250.jpg"],
      [[450,
        353],
       "assets/images/resized/0004/9008/49008v1-max-450x450.jpg"]],
    "attribution": null},
   {"available_sizes":
     [[[150,
        131],
       "assets/images/resized/0011/7975/117975v2-max-150x150.jpg"],
      [[250,
        219],
       "assets/images/resized/0011/7975/117975v2-max-250x250.jpg"],
      [[450,
        395],
       "assets/images/resized/0011/7975/117975v2-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}